Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-30 @ 9:09 AM
Study NCT ID:
NCT01447394
Status:
WITHDRAWN
Last Update Posted:
2012-02-03
First Post:
2011-10-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-08
Completion Date Type:
ESTIMATED
First Submit Date:
2011-10-04
First Submit QC Date:
None
Study First Post Date:
2011-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-02
Last Update Post Date:
2012-02-03
Last Update Post Date Type:
ESTIMATED